Delivery Order SPE2DE24D0013-SPE2D625F1DU9
- Not listed
- The U.S. Defense Logistics Agency, through the Medical Supply Chain division, awarded a $4,080 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on June 18, 2025, with an ultimate completion date of June 26, 2025, is designated as XPCOV2/FLU/RSV-10 and carries no set-aside designation. The delivery order addresses federal requirements for COVID-19, influenza, and respiratory syncytial virus...
- The Defense Logistics Agency awarded a $12,240 firm fixed-price delivery order to Cepheid Inc. for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, with an ultimate completion date of August 15, 2025, was awarded on August 8, 2025, with no set-aside designation. Cepheid, a Sunnyvale, California-based manufacturer specializing in molecular diagnostic systems and test kits, will perform the work at its California...
- The U.S. Defense Department's Medical Supply Chain awarded an $8,160 firm fixed-price delivery order to Cepheid Inc. on August 8, 2025, for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The delivery order, which carries an ultimate completion date of August 15, 2025, will be performed in Sunnyvale, California, where Cepheid maintains its headquarters. This award represents no set-aside designation and reflects the...
- The U.S. Department of Defense Medical Supply Chain awarded a $5,440 delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, for COVID-19, influenza, and respiratory syncytial virus (RSV) testing solutions. This firm fixed-price delivery order, issued on July 23, 2025, with an ultimate completion date of July 30, 2025, carries no set-aside designation and represents performance work in Sunnyvale, California. The delivery order is associated with...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded Cepheid Inc. a delivery order valued at $22,240 on September 9, 2025, for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV). This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by September 16, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. Cepheid is a for-profit...
- The U.S. Defense Logistics Agency (under the Medical Supply Chain function) awarded a $6,800 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on August 18, 2025, with an ultimate completion date of August 25, 2025, is designated as XPCOV2/FLU/RSV-10 and carries no set-aside designation. The award reflects Cepheid's specialized expertise in providing rapid molecular diagnostic testing for...
- The Defense Logistics Agency's Medical Supply Chain branch awarded a $34,000 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic manufacturer based in Sunnyvale, California, for 10 tests of a COVID-19/Influenza/RSV diagnostic kit. The contract, issued on May 29, 2025, is scheduled for completion by June 6, 2025, with performance taking place in Sunnyvale. This delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing support to federal...
- The U.S. Defense Logistics Agency (Medical Supply Chain) awarded a $12,086.88 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The delivery order, issued on August 6, 2025, with completion targeted for August 13, 2025, is designated XPCOV2/FLU/RSV-10 and carries no set-aside designation. This award represents a delivery order issued under one of Cepheid's existing Indefinite Delivery Vehicle (IDV) contracts, likely the...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $13,179.30 firm fixed-price delivery order by the Medical Supply Chain (a Defense agency) on May 2, 2025, with completion scheduled for May 9, 2025. The delivery order, designated 4568136320 ! XPCOV2/FLU/RSV-10, is for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic testing solutions and carries no set-aside designation. The work will be performed in Sunnyvale,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $40,800 by the Defense Department's Medical Supply Chain on August 14, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is for COVID-19, Influenza, and Respiratory Syncytial Virus (RSV) diagnostic testing solutions with an ultimate completion date of August 21, 2025. This award includes no set-aside designation and represents work to be...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F1DU9Delivery Order
The Defense Logistics Agency awarded a $4,080 firm fixed-price delivery order to Cepheid Inc. on June 6, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The order is scheduled for completion by June 13, 2025, with performance occurring at Cepheid's facility in Sunnyvale, California. This delivery order carries no set-aside designation and represents a discrete procurement under the company's existing contract vehicles with federal agencies. Cepheid is a specialized manufacturer of molecular diagnostic systems and test kits headquartered in Sunnyvale, California, with extensive experience serving federal healthcare and defense agencies including the Department of Veterans Affairs and Defense Health Agency. The company maintains significant indefinite delivery contracts with the VA's Veterans Integrated Service Networks, including a $32.8 million IDV with VISN 6 for diagnostic reagents and assays extending through September 2030. This delivery order aligns with Cepheid's core business of providing PCR-based diagnostic equipment and reagent supplies for infectious disease detection across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 6/6/25 |